- Update on Adjuvant Treatment in Resectable Non-Small Cell Lung Cancer and Potential Biomarkers Predicting Postoperative Relapse
-
Lim JU
- KMID: 2537199
- Tuberc Respir Dis.
- 2023 Jan;86(1):14-22.
- doi: 10.4046/trd.2022.0081
A significant proportion of patients with non-small cell lung cancer (NSCLC) is diagnosed in the early and resectable stage. Despite the use of platinum-based adjuvant chemotherapy, there was only a... -
- CITED
-
- Close
- SHARE
-
- Close
- New Targeted Therapy for Non-Small Cell Lung Cancer
-
Chung EK, Yong SH, Lee EH, Kim EY, Chang YS, Lee SH
- KMID: 2537198
- Tuberc Respir Dis.
- 2023 Jan;86(1):1-13.
- doi: 10.4046/trd.2022.0066
Lung cancer ranks first in cancer mortality in Korea and cancer incidence in Korean men. More than half of Korean lung cancer patients undergo chemotherapy, including adjuvant therapy. Cytotoxic agents,... -
- CITED
-
- Close
- SHARE
-
- Close
- Evaluation of MET alteration in EGFR-mutant non-small cell lung cancer patients treated with EGFR tyrosine kinase inhibitor from paired biopsy: A retrospective cohort study
-
Ku BM, Park S, Park S, Jung HA, Sun JM, Lee SH, Ahn JS, Choi YL, Ahn MJ
- KMID: 2538088
- Precis Future Med.
- 2022 Dec;6(4):233-242.
- doi: 10.23838/pfm.2022.00058
Purpose: Mesenchymal-epithelial transition tyrosine kinase receptor (MET) amplification is one of the common acquired resistance mechanisms to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). To evaluate the usefulness... -
- CITED
-
- Close
- SHARE
-
- Close
- Molecular biomarker testing for non–small cell lung cancer: consensus statement of the Korean Cardiopulmonary Pathology Study Group
-
Chang S, Shim HS, Kim TJ, Choi YL, Kim WS, Shin DH, Kim L, Park HS, Lee GK, Lee CH, Korean Cardiopulmonary Pathology Study Group
- KMID: 2515923
- J Pathol Transl Med.
- 2021 May;55(3):181-191.
- doi: 10.4132/jptm.2021.03.23
Molecular biomarker testing is the standard of care for non–small cell lung cancer (NSCLC) patients. In 2017, the Korean Cardiopulmonary Pathology Study Group and the Korean Molecular Pathology Study Group... -
- CITED
-
- Close
- SHARE
-
- Close
- Feasibility of video-assisted thoracoscopic sleeve lobectomy for non-small cell lung cancer
-
Jeon YJ, Yun J, Choi YS, Kim MS, Choi JW
- KMID: 2514318
- Precis Future Med.
- 2021 Mar;5(1):41-47.
- doi: 10.23838/pfm.2020.00184
Purpose: Sleeve lobectomy is a safe and effective surgical procedure for centrally located non-small cell lung cancer (NSCLC). However, the use of video-assisted thoracoscopic surgery (VATS) on bronchial sleeve resection... -
- CITED
-
- Close
- SHARE
-
- Close
- Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer with Brain Metastasis : The Role of Gamma Knife Radiosurgery
-
Lee MH, Cho KR, Choi JW, Kong DS, Seol HJ, Nam DH, Jung HA, Sun JM, Lee SH, Ahn JS, Ahn MJ, Park K, Lee JI
- KMID: 2513858
- J Korean Neurosurg Soc.
- 2021 Mar;64(2):271-281.
- doi: 10.3340/jkns.2020.0135
Objective : Immune checkpoint inhibitors (ICIs) are approved for treating non-small-cell lung cancer (NSCLC); however, the safety and efficacy of combined ICI and Gamma Knife radiosurgery (GKS) treatment remain undefined.... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of oncological outcomes of single-port versus multi-port video-assisted thoracoscopic surgery for non-small-cell lung cancer: a propensity-matched analysis
-
Yoon DW, Choi YS, Sung K, Kim H
- KMID: 2503556
- Precis Future Med.
- 2020 Jun;4(2):60-68.
- doi: 10.23838/pfm.2020.00016
Purpose: There are few reports about oncological outcomes of single-port (SP) video-assisted thoracoscopic surgery (VATS) lobectomy, represented by overall survival (OS), disease-free survival (DFS), and adequacy of lymph node retrieval.... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Characteristics of Korean Patients with Lung Cancer Who Have Programmed Death-Ligand 1 Expression
-
Park HY, Oh IJ, Kho BG, Kim TO, Shin HJ, Park CK, Kwon YS, Kim YI, Lim SC, Kim YC, Choi YD
- KMID: 2450900
- Tuberc Respir Dis.
- 2019 Jul;82(3):227-233.
- doi: 10.4046/trd.2018.0070
BACKGROUND: Programmed death-ligand 1 (PD-L1), a transmembrane protein, binds to the programmed death-1 (PD-1) receptor, and anti-PD-1 therapy enables immune responses against tumors. This study aimed to assess clinical characteristics... -
- CITED
-
- Close
- SHARE
-
- Close
- The Clinical Efficacy and Safety of Four-Weekly Docetaxel as First-Line Therapy in Elderly Lung Cancer Patients with Squamous Cell Carcinoma
-
Choi JH, Choi J, Chung SM, Oh JY, Lee YS, Min KH, Hur GY, Shim JJ, Kang KH, Lee HK, Lee SY
- KMID: 2450898
- Tuberc Respir Dis.
- 2019 Jul;82(3):211-216.
- doi: 10.4046/trd.2018.0019
BACKGROUND: Docetaxel is one of the standard treatments for advanced non-small cell lung cancer. Docetaxel is usually administered in a 3-week schedule, but there is significant toxicity. In this phase... -
- CITED
-
- Close
- SHARE
-
- Close
- Morphologic Evaluation of Primary Non-Small Cell Lung Cancer by 3 Tesla MRI with Free-Breathing Ultrashort Echo Time and Radial T1-Weighted Gradient Echo Sequences: A Comparison with CT Analysis
-
Lee H, Choi E, Lee MK, Zhang Y, Kwon W
- KMID: 2454026
- J Korean Soc Radiol.
- 2019 May;80(3):466-476.
- doi: 10.3348/jksr.2019.80.3.466
PURPOSE: To evaluate morphologic features of primary non-small cell lung cancer using 3 Tesla MRI with free-breathing compared with CT. MATERIALS AND METHODS: Thirty-six patients were enrolled. A 64-channel multidetector CT... -
- CITED
-
- Close
- SHARE
-
- Close
- Provisional Guideline Recommendation for EGFR Gene Mutation Testing in Liquid Samples of Lung Cancer Patients: A Proposal by the Korean Cardiopulmonary Pathology Study Group
-
Shin DH, Shim HS, Kim TJ, Park HS, Choi YL, Kim WS, Kim L, Chang SH, Song JS, Kim HJ, Han JH, Lee CH, Lee GK, Jang SJ, Korean Cardiopulmonary Pathology Study Group
- KMID: 2449337
- J Pathol Transl Med.
- 2019 May;53(3):153-158.
- doi: 10.4132/jptm.2019.02.22
Liquid biopsy for detection of mutation from circulating tumor DNA is a new technology which is attractive in that it is non-invasive. Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic role of beclin-1 in locally advanced non-small cell lung cancer in patients receiving docetaxel-platinum induction chemotherapy
-
Lee HY, Shin JH, Lee KY, Park JK, Sung SW, Kim YS, Kang JH, Kim JO
- KMID: 2441020
- Korean J Intern Med.
- 2019 Mar;34(2):401-408.
- doi: 10.3904/kjim.2017.015
BACKGROUND/AIMS: The outcome of local treatment for advanced non-small cell lung cancer (NSCLC) remains poor, with therapies such as induction chemotherapy (IC) yielding conflicting results. This study aimed to assess... -
- CITED
-
- Close
- SHARE
-
- Close
- Current status of immune checkpoint inhibitors in treatment of non-small cell lung cancer
-
Lim SW, Ahn MJ
- KMID: 2452486
- Korean J Intern Med.
- 2019 Jan;34(1):50-59.
- doi: 10.3904/kjim.2018.179
Lung cancer remains a leading cause of cancer mortality worldwide, including in Korea. Systemic therapy including platinum-based chemotherapy and targeted therapy should be provided to patients with stage IV non-small... -
- CITED
-
- Close
- SHARE
-
- Close
- Pulmonary Subsolid Nodules: An Overview & Management Guidelines
-
Song YS, Park CM
- KMID: 2410720
- J Korean Soc Radiol.
- 2018 May;78(5):309-320.
- doi: 10.3348/jksr.2018.78.5.309
Pulmonary subsolid nodules (SSNs) refer to the pulmonary pure ground-glass nodules and part-solid nodules. SSNs are frequently encountered in clinical settings, such as in screenings conducted with chest computed tomography.... -
- CITED
-
- Close
- SHARE
-
- Close
- Tumor Immunology and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
-
Jung CY, Antonia SJ
- KMID: 2420589
- Tuberc Respir Dis.
- 2018 Jan;81(1):29-41.
- doi: 10.4046/trd.2017.0120
Lung cancer is one of the most commonly diagnosed cancers and the leading cause of cancer-related deaths worldwide. Although progress in the treatment of advanced non-small cell lung cancer (NSCLC)... -
- CITED
-
- Close
- SHARE
-
- Close
- Invasive pulmonary aspergillosis in a patient with metastatic non-small cell lung cancer after treatment with gefitinib
-
Park S, Park S, Choi H, Park JY, Lim HS, Park MJ, Kim SY
- KMID: 2411526
- Korean J Intern Med.
- 2018 Jan;33(1):211-213.
- doi: 10.3904/kjim.2015.276
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Epidermal growth factor receptor mutation and pattern of brain metastasis in patients with non-small cell lung cancer
-
Baek MY, Ahn HK, Park KR, Park HS, Kang SM, Park I, Kim YS, Hong J, Sym SJ, Park J, Lee JH, Shin DB, Cho EK
- KMID: 2411521
- Korean J Intern Med.
- 2018 Jan;33(1):168-175.
- doi: 10.3904/kjim.2015.158
BACKGROUND/AIMS: We investigated the time taken for patients with metastatic non-small cell lung cancer (NSCLC) to develop brain metastases (BM), as well as their subsequent overall median survival following diagnosis,... -
- CITED
-
- Close
- SHARE
-
- Close
- Systemic Sclerosis Associated with Non-small Cell Lung Cancer and Papillary Thyroid Cancer: Case Report and Literature Review
-
Kim HJ, Kim JJ, Park HJ, Kim YT
- KMID: 2410196
- Korean J Med.
- 2017 Jun;92(3):316-320.
- doi: 10.3904/kjm.2017.92.3.316
We report the case of a 52-year-old patient with rheumatic vascular disease (systemic sclerosis), non-small cell lung cancer, and papillary thyroid cancer. Malignant tumors have been described in 3-11% of... -
- CITED
-
- Close
- SHARE
-
- Close
- KRAS Gâ‚â‚‚C mutation as a poor prognostic marker of pemetrexed treatment in non-small cell lung cancer
-
Park S, Kim JY, Lee SH, Suh B, Keam B, Kim TM, Kim DW, Heo DS
- KMID: 2379482
- Korean J Intern Med.
- 2017 May;32(3):514-522.
- doi: 10.3904/kjim.2015.299
BACKGROUND/AIMS: The predictive and prognostic value of KRAS mutation and its type of mutations in non-small cell lung cancer (NSCLC) are controversial. This clinical study was designed to investigate the... -
- CITED
-
- Close
- SHARE
-
- Close
- Does the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor differ according to the type of EGFR mutation in non-small cell lung cancer?
-
Choi YW, Choi JH
- KMID: 2379470
- Korean J Intern Med.
- 2017 May;32(3):422-428.
- doi: 10.3904/kjim.2016.190
An exon 19 deletion and a L858R mutation in exon 21 of the epidermal growth factor receptor (EGFR) are the two most common mutations that predict favorable efficacy of EGFR... -
- CITED
-
- Close
- SHARE
-
- Close
